A group of medical professionals and other health care associates has sued pharmaceutical giant Pfizer Inc. for supposedly discriminating against “white and Asian-American applicants” for one of its fellowship programs.
Earlier this month, Do No Harm — which describes itself as “a diverse group of physicians, healthcare professionals, medical students, patients, and policymakers” who wish to “[p]rotect healthcare from a radical, divisive, and discriminatory ideology” — filed a lawsuit in federal court in Manhattan to end the supposedly discriminatory aspects of Pfizer’s Breakthrough Fellowship Program.
Pfizer claims that it established BFP “to increase minority representation at Pfizer” and “to enhance [its] pipeline of diverse leaders.” To achieve that end, BFP recipients are given funding for: several summer internships, a master’s degree, and pre- and post-graduate employment at the company. However, Pfizer limits those who may apply for BFP. In addition to being a U.S. citizen or resident; a junior at an accredited college or university; interested in a master’s in business, pharmacology, or statistics; and willing to remain in or relocate to New York City, applicants must “[m]eet the program’s goals of increasing the pipeline for Black/African American, Latino/Hispanic and Native Americans.”